❌

Normal view

Received β€” 10 September 2026 ⏭

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment

βœ‡Nature Biotechnology - Issue - nature.com science feeds
By: Alex Zhavoronkov Β· Fedor Galkin Β· Shan Chen Β· Feng Ren Β· Alex Aliper Β· Mikhail Durymanov Β· Denis Sidorenko Β· Hui Cui Β· Jing-Dong J. Han Β· Hao Xu Β· Xiaodong Liu Β· Zuojun Xu Β· Christoph Kuppe Β· M. Austin Argentieri Β· Kejun Ying Β· Ludger J. E. Goeminne Β· Mahdi Moqri Β· Alexander Tyshkovskiy Β· Vadim N. Gladyshev
7 September 2026 at 08:00

Nature Biotechnology, Published online: 07 September 2026; doi:10.1038/s41587-026-03286-y

Six proteomic clocks are applied in a clinical trial to assess anti-aging effects.
There are no more articles
❌